Text-Messaging Prescreening Streamlines Treatment Visits and Care for ICI Toxicities
Elisa Becze, BA, ELS, Editor
Voice
Description
Prescreening patients for immune-related adverse events during treatment with immune checkpoint inhibitors using text messaging may reduce the need for some in-person, preinfusion office visits, researchers reported in JAMA Network Open. The approach may help decrease the burden of cancer care for both patients and providers.